Results
20,303 records
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 36 |  Michael A. RulliRSelf |  MSFTMICROSOFT CORPPartial sale | SELL | $1,001 – $15K | Oct 2, 2026 traded Sep 28, 2026 | |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 36 | Michael A. RulliRSelf | MSFTMICROSOFT CORP Partial sale | SELL | $1,001 – $15K | Oct 2, 2026 traded Sep 28, 2026 | |
Kleinerman ChristianEVP, Product Management |
 SNOWSnowflake Inc.Open-market sale · 10b5-1 plan |
| SELL |
| $5.12M 15.0K sh |
| Oct 2, 2026 traded Oct 1, 2026 |
| 30 | Foundation Fighting Blindness Retinal Degeneration FundDirector, See Remarks |  IRDOpus Genetics, Inc.Open-market sale | SELL | $2.76M 556.0K sh | Oct 2, 2026 traded Sep 30, 2026 |
| 27 | Colendich Katie MarieGC, Corporate Secretary |  ASANAsana, Inc.Open-market sale | SELL | $55K 6,318 sh | Oct 2, 2026 traded Sep 30, 2026 |
| 21 | Bernstein HaroldPresident, R&D & CMO |  MAZEMaze Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $435K 16.1K sh | Oct 2, 2026 traded Oct 1, 2026 |
| 21 | Lee Chan HenrySVP, General Counsel |  ONCBeOne Medicines Ltd.Open-market sale · 10b5-1 plan | SELL | $418K 1,115 sh | Oct 2, 2026 traded Sep 30, 2026 |
| 21 | Spice Adam C.Chief Financial Officer |  RKLBRocket Lab CorpOpen-market sale · 10b5-1 plan | SELL | $6.05M 85.3K sh | Oct 2, 2026 traded Oct 1, 2026 |
| 20 | Michael A. RulliRSelf |  WFCWELLS FARGO & COMPANY/MNPartial sale | SELL | $1,001 – $15K | Oct 2, 2026 traded Sep 3, 2026 |
| 18 | Serafini John SheldonDirector, President and CEO |  HAWKHawkEye 360, Inc.Open-market sale · 10b5-1 plan | SELL | $1.36M 92.3K sh | Oct 2, 2026 traded Oct 1, 2026 |
| 17 | Spice Adam C.Chief Financial Officer | RKLBRocket Lab Corp Open-market sale · 10b5-1 plan | SELL | $2.79M 39.7K sh | Oct 2, 2026 traded Oct 1, 2026 |
| 17 | Spice Adam C.Chief Financial Officer | RKLBRocket Lab Corp Open-market sale · 10b5-1 plan | SELL | $1.09M 15.2K sh | Oct 2, 2026 traded Oct 1, 2026 |
| 16 | Gimbel LisaCHIEF ACCOUNTING OFFICER |  PUBMPubMatic, Inc.Open-market sale · 10b5-1 plan | SELL | $9,495 500 sh | Oct 2, 2026 traded Oct 1, 2026 |
| 11 |  Sahin UgurChief Executive Officer, 10% Owner |  BNTXBioNTech SEOpen-market sale · 10b5-1 plan | SELL | $1.66M 17.0K sh | Oct 2, 2026 traded Oct 1, 2026 |
| 11 | Sahin UgurChief Executive Officer, 10% Owner | BNTXBioNTech SE Open-market sale · 10b5-1 plan | SELL | $1.64M 17.0K sh | Oct 2, 2026 traded Oct 2, 2026 |
| 9 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS |  NTRANatera, Inc.Open-market sale · 10b5-1 plan | SELL | $766K 1,846 sh | Oct 2, 2026 traded Oct 1, 2026 |
| 9 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $394K 954 sh | Oct 2, 2026 traded Oct 1, 2026 |
| 7 | Viljoen NataschaDirector, President & CEO |  NEMNEWMONT Corp /DE/Open-market sale · 10b5-1 plan | SELL | $446K 3,882 sh | Oct 2, 2026 traded Oct 1, 2026 |
| 6 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $82K 200 sh | Oct 2, 2026 traded Oct 1, 2026 |
| 6 | Schubach Sarah ElizabethChief Accounting Officer |  DBXDROPBOX, INC.Open-market sale · 10b5-1 plan | SELL | $66K 2,025 sh | Oct 2, 2026 traded Sep 30, 2026 |
| 6 | Abdelsadek MohamedEVP, Chief Global Solutions |  TRUTransUnionOpen-market sale · 10b5-1 plan | SELL | $16K 250 sh | Oct 2, 2026 traded Oct 1, 2026 |
| 6 | Raghavan VaidyanathanChief Technology Officer |  XMTRXometry, Inc.Open-market sale · 10b5-1 plan | SELL | $56K 549 sh | Oct 2, 2026 traded Oct 2, 2026 |
| 4 | Johnston James DavidExecutive VP, GC, CCO and Secy |  SMCSummit Midstream CorpOpen-market sale · 10b5-1 plan | SELL | $79K 2,600 sh | Oct 2, 2026 traded Oct 1, 2026 |
| 3 | Raghavan VaidyanathanChief Technology Officer | XMTRXometry, Inc. Open-market sale · 10b5-1 plan | SELL | $34K 317 sh | Oct 2, 2026 traded Oct 2, 2026 |
| 3 | Sahni Sanjeev SinghDirector, Chief Executive Officer | XMTRXometry, Inc. Open-market sale · 10b5-1 plan | SELL | $24K 228 sh | Oct 2, 2026 traded Oct 2, 2026 |
| 3 | Raghavan VaidyanathanChief Technology Officer | XMTRXometry, Inc. Open-market sale · 10b5-1 plan | SELL | $35K 343 sh | Oct 2, 2026 traded Oct 2, 2026 |
| 3 | Sahni Sanjeev SinghDirector, Chief Executive Officer | XMTRXometry, Inc. Open-market sale · 10b5-1 plan | SELL | $28K 264 sh | Oct 2, 2026 traded Oct 2, 2026 |
| 3 | Sahni Sanjeev SinghDirector, Chief Executive Officer | XMTRXometry, Inc. Open-market sale · 10b5-1 plan | SELL | $27K 267 sh | Oct 2, 2026 traded Oct 2, 2026 |
| 3 | Raghavan VaidyanathanChief Technology Officer | XMTRXometry, Inc. Open-market sale · 10b5-1 plan | SELL | $30K 284 sh | Oct 2, 2026 traded Oct 2, 2026 |
| 3 | Sahni Sanjeev SinghDirector, Chief Executive Officer | XMTRXometry, Inc. Open-market sale · 10b5-1 plan | SELL | $25K 247 sh | Oct 2, 2026 traded Oct 2, 2026 |
| 3 | Raghavan VaidyanathanChief Technology Officer | XMTRXometry, Inc. Open-market sale · 10b5-1 plan | SELL | $39K 373 sh | Oct 2, 2026 traded Oct 2, 2026 |
| 3 | Sahni Sanjeev SinghDirector, Chief Executive Officer | XMTRXometry, Inc. Open-market sale · 10b5-1 plan | SELL | $7,726 74 sh | Oct 2, 2026 traded Oct 2, 2026 |
| 3 | Sahni Sanjeev SinghDirector, Chief Executive Officer | XMTRXometry, Inc. Open-market sale · 10b5-1 plan | SELL | $3,401 32 sh | Oct 2, 2026 traded Oct 2, 2026 |
| 2 | Kerdman AlinaSVP, Controller & CAO |  CTSHCOGNIZANT TECHNOLOGY SOLUTIONS CORPOpen-market sale · 10b5-1 plan | SELL | $7,906 139 sh | Oct 2, 2026 traded Sep 30, 2026 |
| 0 | Allan JonathanGENERAL COUNSEL & CORP SEC |  STOKStoke Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $17K 627 sh | Oct 2, 2026 traded Oct 2, 2026 |
| 0 | McNamara PeterChief Scientific Officer |  TECXTectonic Therapeutic, Inc.Open-market sale · 10b5-1 plan | SELL | $12K 536 sh | Oct 2, 2026 traded Sep 30, 2026 |
| 42 | Smith Nicholas ConradPRESIDENT AND CFO |  ANROAlto Neuroscience, Inc.Open-market sale | SELL | $2.95M 110.8K sh | Oct 1, 2026 traded Sep 29, 2026 |
| 40 | Sanders Corazon (Corsee) D.Director |  LEGNLegend Biotech CorpOpen-market sale | SELL | $259K 27.4K sh | Oct 1, 2026 traded Sep 29, 2026 |
| 39 | Schuetz Arthur Josef HermannCFO Schmid Group N.V. |  SHMDSCHMID Group N.V.Open-market sale | SELL | $51K 11.4K sh | Oct 1, 2026 traded Sep 30, 2026 |
| 38 | Long QuanDirector |  ATHMAutohome Inc.Open-market sale | SELL | $182K 34.4K sh | Oct 1, 2026 traded Sep 30, 2026 |
| 31 | Zeng YanChief Financial Officer | ATHMAutohome Inc. Open-market sale | SELL | $49K 9,316 sh | Oct 1, 2026 traded Sep 30, 2026 |